TrialJournal for immunotherapy of cancer2021

PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer.

Alexander Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.